Posted on 1/19/21
1 Question T. Rowe Price Needs to Answer
T. Rowe Price Group (NASDAQ:TROW) has been the rare asset manager that's thrived over the past decade with a primary focus on active management. Generally, active . . .
Posted on 1/19/21
Better Buy: Novavax vs. Moderna
Here's a story of two biotechs. Both of them scrambled to develop COVID-19 vaccines last year. One of them, Moderna (NASDAQ:MRNA), ranked as one of the . . .
Posted on 1/19/21
Is Novavax's Growth Story Over?
Most investors would be thrilled with a stock that doubles or triples in value over a 12-month period. A 500% return in a year would be . . .
Posted on 1/19/21
Why Novavax Could Become a Latecomer Leader in the COVID Vaccine Race
Novavax(NASDAQ:NVAX) doesn't rank among the top three leaders in the coronavirus vaccine race. However, don't count the small biotech out. In this Motley Fool Live video . . .
Posted on 1/19/21
Is Pfizer Stock a Buy?
Let me get cut to the chase: Yes, I think Pfizer (NYSE:PFE) stock is a buy. And yes, I realize that could be surprising considering that . . .
Posted on 1/19/21
Should You Buy Johnson & Johnson For Its COVID Vaccine?
So far, some coronavirus vaccine stocks have offered investors enormous gains in a short period of time. For example, Moderna (NASDAQ:MRNA) stock climbed more than 400% . . .
Posted on 1/19/21
Better Buy: Novavax vs. Moderna
Here's a story of two biotechs. Both of them scrambled to develop COVID-19 vaccines last year. One of them, Moderna (NASDAQ:MRNA), ranked as one of the . . .
Posted on 1/19/21
This Is the Best News Yet for Moderna's COVID Vaccine
Moderna (NASDAQ:MRNA) has announced its share of good news in the past couple of months. The biotech company generated positive results in the phase 3 trial . . .
Posted on 1/19/21
State Anticipates Fewer COVID Vaccine Doses Due To U.S. Shortfall
Virginia public health officials said Saturday that the number of COVID-19 vaccine doses sent to the state is likely to decrease — possibly by a significant . . .
Posted on 1/19/21
ProPhase Labs Prices of Public Offering of Common Stock
GARDEN CITY, NY, Jan. 18, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today the pricing of . . .
Posted on 1/18/21
Senseonics Holdings Announces $50M Registered Direct Offering of Common Stock
GERMANTOWN, Md.--(BUSINESS WIRE)--Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems . . .
Posted on 1/18/21
Maryland Reports 45 More Coronavirus Deaths as COVID-19 Hospitalizations Rise Slightly
Maryland reported 45 additional deaths on Friday, raising the state’s total number of coronavirus fatalities to 6,322.There are also 172 deaths suspected to be related to . . .
Posted on 1/18/21
Robert Knight, MD, Joins NexImmune as Chief Medical Officer
GAITHERSBURG, Md., Jan. 18, 2021 (GLOBE NEWSWIRE) -- NexImmune today announced the appointment of Dr. Robert (Bob) Knight as Chief Medical Officer (CMO). Dr. Knight is . . .
Posted on 1/16/21
ProPhase Labs Proposes Public Offering of Common Stock
GARDEN CITY, NY, Jan. 15, 2021 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified medical science and technology company, announced today that it has . . .
Posted on 1/15/21
Gamma Biosciences to Acquire BioMagnetic Solutions
Gamma Biosciences, a life sciences tool platform created by KKR, has agreed to acquire State College, Pennsylvania based, BioMagnetic Solutions (BMS), a next-generation cell selection and . . .
Posted on 1/15/21
State Opens COVID-19 Vaccinations for Virginians 65 and Older
As part of a federal push to speed up the pace of vaccinations, Gov. Ralph Northam said Thursday that the state will immediately expand COVID-19 vaccination . . .
Posted on 1/15/21
Invitae Nabs Bristol Myers Squibb, J&J, Novartis, and Roche for Acute Myeloid Leukemia Project
Genetic testing expert Invitae (NYSE:NVTA) has received the backing of some of the largest pharmaceutical companies in the industry. Bristol Myers Squibb (NYSE:BMY), Johnson & Johnson . . .
Posted on 1/15/21
Could Regeneron Pharmaceuticals Be a Millionaire-Maker Stock?
If you had invested $10,000 during Regeneron Pharmaceuticals' (NASDAQ:REGN) inception in the 1990s, that investment would have turned into more than $317,000 as of Jan. 11, . . .
Posted on 1/15/21
Moderna to Test Coronavirus Vaccine Booster Shot in New Clinical Trial
The first jab of Moderna's (NASDAQ:MRNA) two-shot coronavirus vaccine hasn't made it into the arms of the millions who will eventually receive it, but the company . . .
Posted on 1/15/21
Maryland’s COVID-19 Hospitalizations Drop by 86 Patients
Maryland officials on Thursday reported 86 fewer people currently hospitalized with coronavirus compared to Wednesday.Of the state’s 1,843 current COVID-19 hospital patients, 1,418 are in acute . . .
Posted on 1/15/21
Orthus Health Partners With Healbright To Expand Mental Health Offering
Orthus Health, a leading corporate wellness and condition management company, has partnered with Healbright, a Boston-based leading provider of online mental health services. The partnership will . . .
Posted on 1/14/21
KidsX Selects 13 Startups for Inaugural Cohort
LOS ANGELES--(BUSINESS WIRE)--KidsX, an international consortium of pediatric hospitals focused on improving digital health innovation through collaboration, has selected 13 startup companies to be part of . . .
Posted on 1/14/21
TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020
MALVERN, Pa., Jan. 14, 2021 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (Nasdaq: TELA), a commercial-stage medical technology company focused on designing, developing and marketing a new category . . .
Posted on 1/14/21
Is Moderna Stock Overvalued?
Moderna(NASDAQ:MRNA) ranks as one of the biggest winners of the coronavirus vaccine race. The stock has skyrocketed, but has it gone up too much? In this . . .
Posted on 1/14/21
Aldeyra Therapeutics Prices Public Offering of Common Stock
LEXINGTON, Mass.--(BUSINESS WIRE)--Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a clinical-stage biotechnology company focused on the development of novel therapies with the potential to improve the lives . . .
